Przegląd Dermatologiczny

Abstract

6/2022 vol. 109
Case report

Acute generalized exanthematous pustulosis in temporal association with COVID-19 vaccine

Simay Bayrak Ozturk 1
,
Melike Ordu 2
  1. Department of Dermatology, Aksaray Training and Research Hospital, Aksaray University, Aksaray, Turkey
  2. Department of Pathology, Aksaray Training and Research Hospital, Aksaray University, Aksaray, Turkey
Dermatol Rev/Przegl Dermatol 2022, 109, 464-468
DOI: https://doi.org/10.5114/dr.2022.126606
Online publish date: 2023/04/21
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Introduction:

Acute generalized exanthematous pustulosis is characterized by small, sterile, non-follicular, and sudden-onset pustular reactions on an erythematous surface. It typically involves intertriginous regions and the trunk and is usually accompanied by itching and a feeling of pain in the lesion areas. Often pharmacological treatments and frequent viral eruptions, including enterovirus, coxsackie, Epstein-Barr virus, and hepatitis B, play a role in the etiology of the disease.

Case report:

Here, we present the case of acute generalized exanthematous pustulosis in a 17-year-old young woman triggered by the 1st dose of COVID19 mRNA BioNTech vaccine.

Conclusions:

We are reporting a rare case of vaccine-related acute generalized exanthematous pustulosis, associated with a COVID-19 vaccination.

Keywords

acute generalized exanthematous pustulosis, BioNTech, COVID19 vaccine, virus, treatment

Indeks osobowy
Share
without publication fees
without publication fees
Coverage in
Integrated with
plagiat pl
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications